Cell2Cure ApS will provide patients, physicians and health care systems around the word with easy to use “off-the-shelf” highly effective and safe stem cell products for the treatment of patients with a wide range of diseases.
Cell2Cure is developing stem cell products, that are applied in promising new therapeutic concepts for treatment of several diseases. Pre-clinical studies and clinical phase I and II trials have demonstrated that our stem cell product can be used for treatment of heart diseases and tissue regeneration. Cell2Cure stem cell products are being clinically tested in a wide range of disease indications, where inflammation and tissue regeneration plays a role, and in prevention of organ transplant rejection.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Henrik Harpestrengs Vej 4c, 9302,, Copenhagen,dk2100,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cell2cure.com/
- Keywords
- Copenhagen.
- HQ
- Copenhagen
Cell To Cure Aps Questions
Cell To Cure Aps's website is https://cell2cure.com/
Cell To Cure Aps's LinkedIn profile is https://dk.linkedin.com/company/celltocure
Cell To Cure Aps has
12 employees.
View email and phone details for 12
employees at Cell To Cure Aps.
Cell To Cure Aps's industry is
Biotechnology Research
Cell To Cure Aps's top competitors are
Celcore,
Blue Cell Therapeutics,
Probmet Therapeutics,
Endeavour Invest,
Solid Therapeutics,
Evaxion A/s,
Boost Pharma,
Cbio A/s,
Expres2ion Biotechnologies,
Cardiology Stem Cell Centre.
Cell To Cure Aps's categories are Biotechnology Research
Cell To Cure Aps's founding year is 2018
